Patient-derived iPSC and isogenic controls

Dr. Chengzu Long from NYU has generated patient-derived iPSC lines as well as isogenic controls for the two most common mutations: c.1014+1G>A and p.N173S. These likes are useful for biological research into DHPS function and dysfunction.